Gynecomastia screening: Difference between revisions

	Gynecomastia Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Gynecomastia from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic study of choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
Chest X Ray
CT
MRI
Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Gynecomastia screening On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Gynecomastia screening All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Gynecomastia screening
CDC on Gynecomastia screening
Gynecomastia screening in the news
Blogs on Gynecomastia screening
Directions to Hospitals Treating Gynecomastia
Risk calculators and risk factors for Gynecomastia screening

Revision as of 15:33, 8 August 2017

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:

@@ Line 8: / Line 8: @@
 ==Screening==
-*There is insufficient evidence to recommend routine screening for [disease/malignancy].
+*There is insufficient evidence to recommend routine screening for gynecomastia.
-OR
-*According to the [guideline name], screening for [disease name] is not recommended.
-OR
-*According to the [guideline name], screening for [disease name] by [test 1] is recommended every [duration] among patients with [condition 1], [condition 2], and [condition 3].
 ==References==
 {{Reflist|2}}